BioNTech SE (BNTX) Other Non Operating Income (2020 - 2025)

BioNTech SE has reported Other Non Operating Income for 6 years, with the latest figure at -$452783.9 in Q2 2025.

• Quarterly Other Non Operating Income rose 83.18% year-over-year to -$452783.9 in Q2 2025, while the trailing twelve-month figure through Jun 2025 was -$33.5 million (down 194.48% YoY) and the FY2023 annual result came in at $188.8 million, up 176.8% from the prior year.
• Other Non Operating Income climbed to -$452783.9 in Q2 2025 per BNTX's latest filing, from -$27.3 million in the prior quarter.
• Over five years, Other Non Operating Income peaked at $121.6 million in Q2 2022 and troughed at -$329.8 million in Q4 2022.
• A 5-year average of $2.8 million and a median of $8.3 million in 2021 frame the typical range for Other Non Operating Income.
• The widest YoY moves for Other Non Operating Income: up 312.29% in 2022, down 4161.05% in 2022.
• Over 5 years, Other Non Operating Income stood at $8.1 million in 2021, then tumbled by 4161.05% to -$329.8 million in 2022, then soared by 93.08% to -$22.8 million in 2023, then jumped by 87.0% to -$3.0 million in 2024, then soared by 84.73% to -$452783.9 in 2025.
• According to Business Quant data, Other Non Operating Income over the past three periods registered -$452783.9, -$27.3 million, and -$3.0 million for Q2 2025, Q1 2025, and Q3 2024 respectively.